Mỹ cho phép dùng thuốc Remdesivir trong điều trị bệnh COVID-19

Thông báo của Cơ quan Quản lý Thực phẩm và Dược phẩm Mỹ (FDA) ngày 22/10 cho biết, cơ quan này đã cấp phép sử dụng thuốc Remdesivir (do công ty Gilead Sciences phát triển) trong điều trị bệnh viêm đường hô hấp COVID-19.

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

Bình luận

Xin vui lòng gõ tiếng Việt có dấu

Tin cùng chuyên mục

Công đảng Anh đối mặt nguy cơ chia rẽ sâu sắc

Công đảng Anh đối mặt nguy cơ chia rẽ sâu sắc

Thế giới
(Baothanhhoa.vn) - Nội bộ Công đảng cầm quyền tại Anh đang đối mặt với những bất ổn ngày càng gia tăng khi nhiều nghị sĩ và quan chức trong đảng kêu gọi Thủ tướng Keir Starmer từ chức, làm dấy lên khả năng diễn ra một cuộc chuyển giao quyền lực trong thời gian tới.
Chứng nhận tín nhiệm mạng
Việt Long Phần mềm tòa soạn
hội tụ thông minh